The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. This year’s metric has recorded a Price decrease of -26.58%. However, over the past six months, we’ve seen a stronger performance of -38.38%. The price of BEAM leaped by -12.28% over the last 30 days. And in the last five days, it has fallen by -1.43%.
Currently, the stock price of Beam Therapeutics Inc (BEAM) is $17.6. In the most recent trading session, the stock underwent a significant upswing, peaking at $80.0 after opening at $17.51. The stock touched a low of $20.0 before closing at $17.52.
The stock market performance of Beam Therapeutics Inc has been fairly unsteady. Over the last year, the company’s stock hit its highest at $35.25 on 02/18/25, while the lowest price during the same time frame was $13.52, recorded on 04/07/25.
52-week price history of BEAM Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Beam Therapeutics Inc’s current trading price is -50.06% away from its 52-week high, while its distance from the 52-week low is 30.17%. The stock’s price range for this period has been between $13.52 and $35.25. The Healthcare sector company’s shares saw a trading volume of about 1.55 million for the day, which was lower than the average daily volume of 2.13 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Beam Therapeutics Inc (BEAM) has experienced a quarterly rise of 2.12% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.78B and boasts a workforce of 483 employees.
Expert Opinions: Analysts’ Ratings for Beam Therapeutics Inc
As of right now, 11 analysts are rating Beam Therapeutics Inc as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 3 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 18.44, with a change in price of -5.50. Similarly, Beam Therapeutics Inc recorded 2,299,088 in trading volume during the last 100 days, posting a change of -23.61%.
BEAM’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for BEAM stands at 0.15. Similarly, the long-term debt-to-equity ratio is also 0.14.
BEAM Stock Stochastic Average
As of today, the raw stochastic average of Beam Therapeutics Inc over the past 50 days is 25.26%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 18.70%. Additionally, the Stochastic %K and %D values for the company were 12.09% and 7.73%, respectively, over the past 20 days.
